Johnson & Johnson to restructure orthopedic business
J&J's 3rd quarter earnings report reveals a shortfall in medical device sales, prompting a 2-year restructuring process of its orthopedic business. Product exit
Source: beckersspine.com
Page 49 - Johnson Amp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johnson Amp Today - Breaking & Trending Today
Baxter and 5 More Medical Device Stocks Primed to Bounce Back
Some investors have worried that new weight-loss drugs could undermine demand for some medical devices.
Source: marketwatch.com
Johnson & Johnson's orthopedic activity: 3 notes
Stay up-to-date with Johnson & Johnson's orthopedic activity: restructuring, revenue increases, and new FDA clearance for a spine system.
Source: beckersspine.com
Johnson & Johnson puts orthopedics unit under the knife
Johnson & Johnson will excise less profitable lines and markets within its Depuy Synthes orthopedics business over the next two years, management revealed in its quarterly investor call on Oct. 16. Paring its products and related pursuits could cost as much as $800 million by the end of 2025, J&J Chief Financial Officer Joe Wolk said.
Source: bioworld.com
Stocks making the biggest moves premarket: WH, DLTR, JNJ
These are the stocks posting the largest moves in premarket trading.
Source: cnbc.com